Today: 21 May 2026
P&G stock slides to start 2026 as investors eye Jan. 22 earnings and the $140 level
3 January 2026
2 mins read

P&G stock slides to start 2026 as investors eye Jan. 22 earnings and the $140 level

NEW YORK, Jan 3, 2026, 14:33 ET — Market closed

  • P&G fell about 1% in Friday’s session, extending a multi-day losing streak.
  • The broader market edged higher, led by chipmakers, while consumer staples were mixed.
  • Next on the calendar: P&G’s fiscal Q2 earnings call on Jan. 22.

Procter & Gamble’s shares closed down about 1.1% at $141.79 on Friday, extending the consumer products maker’s pullback into the first trading session of 2026.

The decline left P&G on a four-session losing streak even as Wall Street posted modest gains, a divergence that puts the focus back on defensives at the start of the year.

That matters now because investors have been rotating toward higher-beta areas that led the rebound late Friday, while steadier consumer-staples names have struggled to keep pace. The Consumer Staples Select Sector SPDR Fund, an exchange-traded fund (ETF) that tracks large U.S. staples stocks, was little changed.

On the day, the Dow and S&P 500 ended higher as chipmakers and industrials lifted the tape, Reuters reported. Joe Mazzola, head of trading and derivatives strategist at Charles Schwab, described the mood as “buy the dip, sell the rip” — shorthand for investors buying pullbacks and trimming into rallies. Reuters

P&G lagged a mixed set of large consumer names. Estée Lauder rose nearly 2% while Colgate-Palmolive fell about 1.7% in the same session, according to MarketWatch data.

At Friday’s close, P&G sat well below its 52-week high of $179.99 and not far above its 52-week low of $138.14, Reuters data show.

The gap underscores how quickly sentiment can shift for staples stocks when the market’s leadership narrows and investors chase growth themes. It also raises the bar for the next company update, with P&G set to address demand trends and costs later this month.

P&G is widely held as a defensive stock because it sells everyday essentials, from laundry and cleaning products to baby care and grooming. In that corner of the market, traders tend to watch price increases versus unit volumes, along with input costs and currency swings that can pressure margins.

Before the next session on Monday, investors will be watching next week’s U.S. labor market data and the interest-rate outlook after a choppy start to the year, Reuters reported. Policy uncertainty, including tariffs, remains part of the backdrop for companies with global supply chains.

The next known P&G catalyst is its fiscal second-quarter earnings conference call, scheduled for Jan. 22 at 8:30 a.m. ET, the company’s investor relations website shows.

On the chart, traders are likely to focus on whether the stock holds the $140 area near recent lows and whether it can reclaim its 50-day moving average, around $146.57, a commonly watched trend gauge.

For now, with the market shut for the weekend, P&G enters Monday with momentum pointed lower — and with earnings looming as the next test of whether the stock’s slump is a rotation-driven dip or something more fundamental.

Stock Market Today

  • Sharda Cropchem Earnings Reveal Weak Cash Flow Despite Profit Growth
    May 20, 2026, 9:35 PM EDT. Sharda Cropchem Limited's (NSE:SHARDACROP) recent earnings report shows a statutory profit of ₹6.81 billion for the year ending March 2026, but free cash flow was significantly lower at ₹1.6 billion, resulting in a high accrual ratio of 0.23. This suggests the company's cash conversion is less than ideal, raising concerns about the sustainability of its earnings. Despite this, Sharda Cropchem's earnings per share (EPS) has grown impressively over the past three years. Investors remain cautious due to three warning signs surrounding the stock, with one marked as significant. The gap between profit and cash flow indicates that reported profits may overstate the company's underlying earning power.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Defense and space stocks jump to start 2026 as Boeing, Rocket Lab lead gains
Previous Story

Defense and space stocks jump to start 2026 as Boeing, Rocket Lab lead gains

Thermo Fisher (TMO) stock rises 2% to start 2026 as earnings, key data loom
Next Story

Thermo Fisher (TMO) stock rises 2% to start 2026 as earnings, key data loom

Go toTop